HTS

Stack Capital Holding Hopper Partners With Korean-Based Lotte Card

Retrieved on: 
星期二, 五月 21, 2024
Partnership, Travel, Lotte Card, TSX, HTS

TORONTO, May 21, 2024 (GLOBE NEWSWIRE) -- Stack Capital Group Inc., (TSX:STCK and STCK.WT) is pleased to announce that Hopper, Inc. (“Hopper”), an existing portfolio holding, has entered into strategic partnership with Lotte Card, a leading Korean credit card issuer with 9+ million card members, along with 3+ million affiliated merchants, involved with card business, installment finance, and general loans.

Key Points: 
  • TORONTO, May 21, 2024 (GLOBE NEWSWIRE) -- Stack Capital Group Inc., (TSX:STCK and STCK.WT) is pleased to announce that Hopper, Inc. (“Hopper”), an existing portfolio holding, has entered into strategic partnership with Lotte Card, a leading Korean credit card issuer with 9+ million card members, along with 3+ million affiliated merchants, involved with card business, installment finance, and general loans.
  • “Another example of an incredible global partnership for Hopper, further highlighting the strength and reputation of its HTS solution,” said Jeff Parks, CEO of Stack Capital.
  • “HTS now accounts for two-thirds of Hopper’s business, and we anticipate that number will continue to increase.
  • We look forward to more HTS partnership announcements in the coming months.”

CHOP and NJ HTS Launch New Website Dedicated to Promoting Traffic Safety

Retrieved on: 
星期二, 五月 7, 2024
Rail transport by country, Information technology, Transport, Hospital, Safety, CHOP, Research, Collection, Doctor of Philosophy, CIRP, HTS, Department of motor vehicles, Fatality, Crash, Death, Children's Hospital of Philadelphia, Pedestrian

PHILADELPHIA, May 7, 2024 /PRNewswire/ -- Children's Hospital of Philadelphia (CHOP)'s New Jersey Safety and Health Outcomes (NJ-SHO) Center for Integrated Data and the New Jersey Division of Highway Traffic Safety (HTS) are pleased to announce the launch of njsho.chop.edu, a website that features an interactive data dashboard that enables users to visualize, monitor, and track important traffic safety measures across communities and over time.

Key Points: 
  • The NJ-SHO Center for Integrated Data team is reimagining how data are collected, integrated, analyzed, and shared to support safe transport in New Jersey.
  • The data dashboard offers access to previously unavailable data to guide and evaluate local and statewide solutions for reducing the burden of injury and deaths.
  • The website also shares evidence-based injury prevention, transportation equity, and traffic safety resources to help drive positive change throughout the state.
  • "We hope that regional, local, and community partners will use our dashboard to implement safety efforts that ultimately move the needle on reducing crashes."

Chart Industries Reports First Quarter 2024 Financial Results

Retrieved on: 
星期五, 五月 3, 2024
Hydrogen, Transfer, PFAS, Energy Observer, Howden, EPA, Safety, Cedar, CBE, FCF, Partnership, Collection, Artificial intelligence, Water, History, Urbanization, Intelligence, CCUS, Public expenditure, HTS, Digital, Chart, EPS, CTS, Ageing, RSL, Growth, Video game

ATLANTA, May 03, 2024 (GLOBE NEWSWIRE) -- Chart Industries, Inc. (NYSE: GTLS) (“Chart”) today reported results for the first quarter ended March 31, 2024.

Key Points: 
  • ATLANTA, May 03, 2024 (GLOBE NEWSWIRE) -- Chart Industries, Inc. (NYSE: GTLS) (“Chart”) today reported results for the first quarter ended March 31, 2024.
  • First quarter 2024 Segment Results (as compared to the first quarter 2023, pro forma continuing operations unless noted otherwise):
    Cryo Tank Solutions (“CTS”): First quarter 2024 CTS orders of $159.3 million decreased 4.5% when compared to the first quarter 2023, driven by a large rail car order in the first quarter 2023 and increased 1.4% sequentially to the fourth quarter 2023, with continuing pickup in demand in EMEA industrial gas.
  • Specialty Products: First quarter 2024 Specialty Products orders of $391.3 million increased 39.2% when compared to the first quarter 2023.
  • Also, we won 22 Digital Uptime projects in the first quarter 2024, the most in any quarter since we acquired Howden.

Global RNAi Therapeutics Market Insights & Forecasts with Potential Impact of COVID-19 2024-2028 Featuring Sanofi, Alnylam, Arrowhead, Arbutus Biopharma, Benitec Biopharma, Sirnaomics - ResearchAndMarkets.com

Retrieved on: 
星期五, 五月 3, 2024
Biotechnology, Pharmaceutical, Genetics, Health, Molecule, MicroRNA, Investment, RNA interference, Hospital, Infection, RNA, Research, Liver, HTS, Therapy, DSM-IV codes, COVID-19, Prevalence, Row

The "Global RNAi Therapeutics Market (By Molecule Type, Application, End-User & Region): Insights & Forecast with Potential Impact of COVID-19 (2024-2028)" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global RNAi Therapeutics Market (By Molecule Type, Application, End-User & Region): Insights & Forecast with Potential Impact of COVID-19 (2024-2028)" report has been added to ResearchAndMarkets.com's offering.
  • The global RNAi therapeutics market is expected to record a value of US$1.39 billion in 2028, progressing at a CAGR of 9.98%, over the period 2024-2028.
  • Whereas, the global RNAi therapeutics market is split into research & academic laboratories and hospitals & diagnostic laboratories, in terms of end-user.
  • The report provides a comprehensive analysis of the global RNAi therapeutics market segmented on the basis of molecule type, application, end-user and region, with potential impact of COVID-19.

Tariffy Empowers Customs Brokers and Companies to Take Control of International Trade Compliance with AI

Retrieved on: 
星期三, 五月 1, 2024
Multimedia, HTS, Harmonized System, Internet, Chocolate, Language, CIQ, ChatGPT, TARIC, HS, Online shopping

TALLINN, Estonia, May 1, 2024 /PRNewswire-PRWeb/ -- Businesses shipping goods internationally must follow a myriad of policies to ensure continued compliance with international trade policies. And to remain in compliance, customs brokers and companies spend a lot of time and energy to get the job done. One of these time-consuming processes is finding and using the correct Harmonized System codes (HS codes) to classify their shipments. But identifying the correct codes can be time-consuming, expensive, and cumbersome—until now, thanks to Tariffy.

Key Points: 
  • And to remain in compliance, customs brokers and companies spend a lot of time and energy to get the job done.
  • Think of Tariffy as ChatGPT's cousin, built specifically for the international trade and shipping industry.
  • Tariffy is an AI-powered assistant specifically built to tackle the headache-inducing world of HS codes in international trade.
  • "Think of Tariffy as ChatGPT's cousin, built specifically for the international trade and shipping industry," said Arnaud Granal, founder of Tariffy.

High Temperature Superconductors, Inc. Powers Up: $5M ARPA-E Program Work Begins

Retrieved on: 
星期二, 四月 23, 2024
Other Manufacturing, Technology, Research, Semiconductor, Engineering, Aerospace, Manufacturing, Hardware, Science, ACT, DOE, University, Materials science, Education minister, Partnership, Florida State University, Business, HTS, FSU, ARPA, PLD, Engine department, Management

As previously announced , HTSI received a $5 million ARPA-E award, the largest fraction of the award granted under the $10 million fund.

Key Points: 
  • As previously announced , HTSI received a $5 million ARPA-E award, the largest fraction of the award granted under the $10 million fund.
  • In fulfillment of the program, HTSI will develop a new PLD tool that increases production throughput up to five to ten times higher than present-day levels.
  • Simultaneously, HTSI unveils strategic collaborations with Advanced Conductor Technologies (ACT) and Florida State University's MagLab , setting the stage for groundbreaking advancements in superconductor materials.
  • HTSI eagerly anticipates the opportunities these developments will unlock in shaping the future of our industry," said Shelton.

Global Satellite Connectivity Research Report 2024 with Analyst Insights on Technology Innovation and Customized Solutions & Foster Interoperability and Cross-Platform Integration - ResearchAndMarkets.com

Retrieved on: 
星期四, 四月 11, 2024
Satellite, Technology, USD, GEO, Agriculture, Porter's five forces analysis, ITS, LEO, Internet of things, SWOT, Commercial, MEO, Privatization, Communication, Artificial intelligence, Component, Growth, HTS, Intelligent transportation system, Telecommunications, Aviation, Communications satellite

The Global Satellite Connectivity market showcased growth at a CAGR of 13.92% during 2020-2023.

Key Points: 
  • The Global Satellite Connectivity market showcased growth at a CAGR of 13.92% during 2020-2023.
  • The satellite communication sector has seen significant change in the last few years as a result of new business models and technology breakthroughs.
  • This is leading to serious concerns about the long-term viability of satellite communication (satcom) operators in a rapidly changing connectivity market.
  • These developments also spur innovation and increase the capabilities of satellite connectivity solutions.

Metrion Biosciences Enhances High Throughput Screening Services With Access to Enamine Compound Libraries

Retrieved on: 
星期四, 四月 11, 2024
Research, Technology, Medical Devices, Other Technology, Health Technology, Biotechnology, Pharmaceutical, Health, Science, Other Science, Penta, Safety, REAL, Projection screen, Library, CNS, HTS, Drug discovery, Electrophysiology

Metrion Biosciences Limited (“Metrion”), the specialist ion channel and cardiac safety screening contract research organisation (CRO) and drug discovery company, and Enamine Ltd (“Enamine”), the global leader in supplying small molecules and early drug discovery services, announced that Metrion has enhanced its High Throughput Screening (HTS) services with the addition of access to Enamine’s compound libraries.

Key Points: 
  • Metrion Biosciences Limited (“Metrion”), the specialist ion channel and cardiac safety screening contract research organisation (CRO) and drug discovery company, and Enamine Ltd (“Enamine”), the global leader in supplying small molecules and early drug discovery services, announced that Metrion has enhanced its High Throughput Screening (HTS) services with the addition of access to Enamine’s compound libraries.
  • The Enamine compound library collection is the largest in the world and includes both CNS and ion channel focused target libraries.
  • The libraries can be split into discrete screening sets, enabling increased flexibility and efficiencies in screening and target identification.
  • We are delighted that Metrion is adding access to our libraries to its HTS services offering.

Hypertec Wins Best Intel Strategic OEM Partner in Canada Award

Retrieved on: 
星期四, 四月 18, 2024
Immersion, AI, Partnership, Acceleration, TRIDENT, TCO, Life, HTS, Environment, Newsroom, Intel, Growth, Semiconductor

MONTRÉAL, April 18, 2024 /PRNewswire-PRWeb/ -- Hypertec continues to be recognized for its innovative work in sustainable computing. Hypertec was recently named Best Strategic OEM Partner in Canada by Intel as part of its 2024 Americas Partner Awards. This accolade underscores the company's ongoing commitment to driving innovation in the sustainable computing space.

Key Points: 
  • Hypertec was recently named Best Strategic OEM Partner in Canada by Intel as part of its 2024 Americas Partner Awards.
  • "Together with our long-standing partner, Intel, we are focusing on sustainability and cutting-edge solutions that create a win-win for businesses and the environment.
  • The Intel Partner Alliance awards recognize member companies that excel in leveraging Intel's technology to deliver groundbreaking AI solutions.
  • "Together with our long-standing partner, Intel, we are unlocking the full potential of technology for our North American customers.

Drug Discovery and Early Development Outsourcing Services Industry Analysis - M&As, Partnerships and the Shift Toward an End-to-end CRDMO Model will Boost Sector Expansion - ResearchAndMarkets.com

Retrieved on: 
星期五, 四月 5, 2024
Biotechnology, Health, Science, Pharmaceutical, Research, ChromeOS, ROI, Growth, Neurology, PROTAC, Drug discovery, Partnership, COVID-19, HTS, NGS, RNA, Artificial intelligence, Overalls, Drug development, Machine learning, Fine chemical

The "Growth Opportunities in Drug Discovery and Early Development Outsourcing Services" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Growth Opportunities in Drug Discovery and Early Development Outsourcing Services" report has been added to ResearchAndMarkets.com's offering.
  • Overall R&D expenditure totals about $276.81 billion, with a slow 2.5% growth between 2023 to 2024.
  • This activity is improving the partnership landscape across the global drug discovery and preclinical development industry.
  • Last, the larger CROs have developed separate lab testing divisions that allow them to focus on specific drug discovery and preclinical development testing services.